These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 28933682

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity.
    Gregory AE, van Schaik EJ, Fratzke AP, Russell-Lodrigue KE, Farris CM, Samuel JE.
    Cell Rep Med; 2021 Dec 21; 2(12):100461. PubMed ID: 35028605
    [Abstract] [Full Text] [Related]

  • 26. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats.
    Arricau-Bouvery N, Souriau A, Bodier C, Dufour P, Rousset E, Rodolakis A.
    Vaccine; 2005 Aug 15; 23(35):4392-402. PubMed ID: 16005747
    [Abstract] [Full Text] [Related]

  • 27. Serological response in sheep vaccinated against Coxiella burnetii (Q fever).
    Lang GH, Prescott JF, Williams JC.
    Can Vet J; 1994 Jun 15; 35(6):373-4. PubMed ID: 8069839
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of the efficacy of Q fever vaccines against Coxiella burnetii experimental challenge in pregnant goats.
    Souriau A, Arricau-Bouvery N, Bodier C, Rodolakis A.
    Ann N Y Acad Sci; 2003 Jun 15; 990():521-3. PubMed ID: 12860684
    [No Abstract] [Full Text] [Related]

  • 29. Synthetic Particulate Subunit Vaccines for the Prevention of Q Fever.
    Sam G, Plain K, Chen S, Islam A, Westman ME, Marsh I, Stenos J, Graves SR, Rehm BHA.
    Adv Healthc Mater; 2024 Mar 15; 13(7):e2302351. PubMed ID: 38198823
    [Abstract] [Full Text] [Related]

  • 30. The effectiveness of Coxiella burnetii vaccines in occupationally exposed populations: a systematic review and meta-analysis.
    O'Neill TJ, Sargeant JM, Poljak Z.
    Zoonoses Public Health; 2014 Mar 15; 61(2):81-96. PubMed ID: 23721172
    [Abstract] [Full Text] [Related]

  • 31. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
    Dold C, Zhu H, Silva-Reyes L, Blackwell L, Linder A, Bewley K, Godwin K, Fotheringham S, Charlton S, Kim YC, Pollard AJ, Rollier CS.
    Vaccine; 2023 May 05; 41(19):3047-3057. PubMed ID: 37037709
    [Abstract] [Full Text] [Related]

  • 32. Protein array of Coxiella burnetii probed with Q fever sera.
    Wang X, Xiong X, Graves S, Stenos J, Wen B.
    Sci China Life Sci; 2013 May 05; 56(5):453-9. PubMed ID: 23633077
    [Abstract] [Full Text] [Related]

  • 33. Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Bond KA, Franklin LJ, Sutton B, Firestone SM.
    Vaccine; 2017 Dec 18; 35(51):7084-7087. PubMed ID: 29132996
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Preclinical Animal Models for Q Fever Vaccine Development.
    Tesfamariam M, Binette P, Long CM.
    Front Cell Infect Microbiol; 2022 Dec 18; 12():828784. PubMed ID: 35223553
    [Abstract] [Full Text] [Related]

  • 36. Q fever: the long journey to control by vaccination.
    Marmion B.
    Med J Aust; 2007 Feb 19; 186(4):164-6. PubMed ID: 17309414
    [No Abstract] [Full Text] [Related]

  • 37. Unveiling promising immunogenic targets in Coxiella burnetii through in silico analysis: paving the way for novel vaccine strategies.
    Kodori M, Amani J, Ahmadi A.
    BMC Infect Dis; 2023 Dec 21; 23(1):902. PubMed ID: 38129801
    [Abstract] [Full Text] [Related]

  • 38. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    Gong W, Wang P, Xiong X, Jiao J, Yang X, Wen B.
    PLoS One; 2015 Dec 21; 10(4):e0124664. PubMed ID: 25909586
    [Abstract] [Full Text] [Related]

  • 39. Antigenic analysis for vaccines and diagnostics.
    Hendrix LR, Chen C.
    Adv Exp Med Biol; 2012 Dec 21; 984():299-328. PubMed ID: 22711639
    [Abstract] [Full Text] [Related]

  • 40. Coxiella burnetii persistence in three generations of mice after application of live attenuated human M-44 vaccine against Q fever.
    Freylikhman O, Tokarevich N, Suvorov A, Vorobiova E, Totolian A.
    Ann N Y Acad Sci; 2003 Jun 21; 990():496-9. PubMed ID: 12860680
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.